CCL22, also known as macrophage-derived chemokine (MDC), is a conventional CC chemokine that is expressed constitutively under homeostatic conditions and can be induced in several cell types upon activation. Mouse CCL22 is expressed at high levels in dendritic cells and activated B lymphocytes. Low levels of mouse MDC mRNA is also detectable in lung, unstimulated spleen cells, lymph node cells, and in thymocytes. Constitutive expression of CCL22 is mediated by T cell–derived GM-CSF. The only known receptor for CCL22 is CCR4, which is mainly expressed by activated Th2-biased CD4+ T cells and by regulatory T cells. CCL22 displays chemotactic activity for natural killer cells, chronically activated T lymphocytes, monocytes, and dendritic cells, and may play a role in recruiting activated T lymphocytes to inflammatory sites and other aspects of activated T lymphocyte physiology.

PRODUCT DETAILS

Clone: W20219K

Antibody Type: Monoclonal

Reactivity: Mouse

Format: CCL22

Host: Rat

Isotype: IgG2b, κ

Applications: ICFC - Quality tested

Regulatory Status: RUO

Data Sheets: TDS | SDS

Note to Purchaser: This product is manufactured and supplied by BioLegend, Inc. under an agreement between BioLegend, Inc. and Cytek Biosciences, Inc. Information related to this product is provided by BioLegend, Inc.